Table 3.
Oncological outcomes after EBS
| Case | Surgical margin | Local recurrence |
Distant relapse after EBS |
Prognosis | Follow-up (mo) | ||||
|---|---|---|---|---|---|---|---|---|---|
| Yes/no | Duration after EBS (mo) | Treatment | Region | Duration after EBS (mo) | Treatment | ||||
| 1 | - | No | Bone | 15 | C | DOD | 24 | ||
| 2 | - | No | Neck | 228 | R | AWD | 266 | ||
| 3 | + | No | Bone | 28 | S+R | DOD | 48 | ||
| 4 | - | No | Bone, choroid plexus, eye | 1 | BSC | DOD | 9 | ||
| 5 | + | Yes | 46 | S+R | Bone | 46 | C+R | DOD | 72 |
| 6 | + | No | None | DOC | 80 | ||||
| 7 | + | Yes | 13 | R | None | DOD | 39 | ||
| 8 | - | No | None | NED | 120 | ||||
| 9 | - | No | Lung, bone, lymph nodes | 7 | BSC | DOD | 10 | ||
| 10 | - | No | Bone, lung, kidney, pancreas | 36 | C+R | DOD | 97 | ||
| 11 | - | Yes | 6 | S+R+C | Lung, lymph nodes | 6 | S+C | DOD | 14 |
| 12 | + | No | Bone | 18 | R | AWD | 72 | ||
| 13 | + | Yes | 53 | BSC | Lung, bone, thyroid | 7 | S+C+RAI+R | DOD | 55 |
| 14 | + | No | Bone | 6 | BSC | DOD | 20 | ||
| 15 | + | Yes | 12 | S | None | AWD | 42 | ||
| 16 | - | No | Bone | 18 | S | AWD | 36 | ||
| 17 | - | No | None | NED | 36 | ||||
| 18 | - | No | Lung | 21 | RAI | AWD | 24 | ||
EBS, en bloc spondylectomy; C, chemotherapy; DOD, dead of disease; R, radiation therapy; AWD, alive with disease; S, surgery; DOC, dead from other causes; NED, no evidence of disease; BSC, best supportive care; RAI, radioactive iodine therapy.